If your drug is on the list, go to the link below and click on your
drug in the FDA list.
Good Luck,
Chris
=========
From: FDA MedWatch
Date: 11/15/2012
Subject: FDA MedWatch - October 2012 Safety Labeling Changes includes
58 products with revisions to Prescribing Information
The MedWatch October 2012 Safety Labeling Changes posting includes 58
products with safety labeling changes to the following sections:
CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS and
PATIENT PACKAGE INSERT.
The "Summary Page" provides a listing of drug names and safety
labeling sections revised:
http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm326133.htm The following drugs had modifications to the CONTRAINDICATIONS and/or
WARNINGS sections:
mainframetech wrote:
> If your drug is on the list, go to the link below and click on your
> drug in the FDA list.
> Good Luck,
> Chris
> =========
> From: FDA MedWatch
> Date: 11/15/2012
> Subject: FDA MedWatch - October 2012 Safety Labeling Changes includes
> 58 products with revisions to Prescribing Information
> The MedWatch October 2012 Safety Labeling Changes posting includes 58
> products with safety labeling changes to the following sections:
> CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS and
> PATIENT PACKAGE INSERT.
> The "Summary Page" provides a listing of drug names and safety
> labeling sections revised:
> http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm326133.htm > The following drugs had modifications to the CONTRAINDICATIONS and/or
> WARNINGS sections:
Interesting! I am not on any of those things now. The proton pump inhibitors all were nightmare drugs for me and I do mean literally, among other things. The Dr. who prescribed them for me did not prescribe for short term use even though it clearly stated that in the prescribing information. When I started out, the longest I could take them was maybe 2-3 months before the troubles began. But then the problems started coming sooner. At 2-3 weeks. And then with the last one I tried, the effects were pretty immediate. It was as though my body was telling me... Oh no! You're not putting *that* crap in me again. Are you?
The odd thing to me was that the Dr. just had me keep trying med after med all of the same class. As though he expected a different reaction to the other ones. But for me? The same reaction to all of them. My SIL had bad reactions or simply no reaction to some of them and was able to find one that worked for her. And I know people who swear by the things. However one person who takes them has chronic migraines and refuses to listen to me when I say that the meds caused migraines for me. She just happily swallows her pills and then takes other pills as well to try to knock out the migraines!
Statins are the same way for me. My body simpy does not like them and will do bad things if I take them.
> If your drug is on the list, go to the link below and click on your
> drug in the FDA list.
> Good Luck,
> Chris
> =========
> From: FDA MedWatch
> Date: 11/15/2012
> Subject: FDA MedWatch - October 2012 Safety Labeling Changes includes
> 58 products with revisions to Prescribing Information
> The MedWatch October 2012 Safety Labeling Changes posting includes 58
> products with safety labeling changes to the following sections:
> CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS and
> PATIENT PACKAGE INSERT.
> The "Summary Page" provides a listing of drug names and safety
> labeling sections revised:
> http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm326133.htm > The following drugs had modifications to the CONTRAINDICATIONS and/or
> WARNINGS sections:
mainframetech <mainframet...@yahoo.com> wrote:
> If your drug is on the list, go to the link below and click on your
> drug in the FDA list.
> Good Luck,
> Chris
> =3D=3D=3D=3D=3D=3D=3D=3D=3D
> From: FDA MedWatch
> Date: 11/15/2012
> Subject: FDA MedWatch - October 2012 Safety Labeling Changes includes
> 58 products with revisions to Prescribing Information
> The MedWatch October 2012 Safety Labeling Changes posting includes 58
> products with safety labeling changes to the following sections:
> CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS and
> PATIENT PACKAGE INSERT.
> The "Summary Page" provides a listing of drug names and safety
> labeling sections revised:
> http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm326133.htm > The following drugs had modifications to the CONTRAINDICATIONS and/or
> WARNINGS sections:
Needless to say, the new contraindication warnings on statins do NOT shock
me. I found out from reading Doctor Sinatra's book that the long term use
of statins can even cause heart disease and cancer.
$no_spam#ma_dot_zuiderweg_@_me_dot_com#maps_on$> wrote:
> mainframetech stelde dit idée voor :
> > If your drug is on the list, go to the link below and click on your
> > drug in the FDA list.
> > Good Luck,
> > Chris
> > =========
> > From: FDA MedWatch
> > Date: 11/15/2012
> > Subject: FDA MedWatch - October 2012 Safety Labeling Changes includes
> > 58 products with revisions to Prescribing Information
> > The MedWatch October 2012 Safety Labeling Changes posting includes 58
> > products with safety labeling changes to the following sections:
> > CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS and
> > PATIENT PACKAGE INSERT.
> > The "Summary Page" provides a listing of drug names and safety
> > labeling sections revised:
> >http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm326133.htm > > The following drugs had modifications to the CONTRAINDICATIONS and/or
> > WARNINGS sections:
From: FDA MedWatch
Date: 11/15/2012
Subject: FDA MedWatch - October 2012 Safety Labeling Changes includes
58 products with revisions to Prescribing Information
The MedWatch October 2012 Safety Labeling Changes posting includes 58
products with safety labeling changes to the following sections:
CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS and
PATIENT PACKAGE INSERT.
The "Summary Page" provides a listing of drug names and safety
labeling sections revised:
http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm326133.htm The following drugs had modifications to the CONTRAINDICATIONS and/or
WARNINGS sections:
Thanks again for your regular updates with these lists. There is one there I take, (januvia) I think the benefits seem to outweigh the side effects for now.
Craig
> From: FDA MedWatch
> Date: 11/15/2012
> Subject: FDA MedWatch - October 2012 Safety Labeling Changes includes
> 58 products with revisions to Prescribing Information
> The MedWatch October 2012 Safety Labeling Changes posting includes 58
> products with safety labeling changes to the following sections:
> CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS and
> PATIENT PACKAGE INSERT.
> The "Summary Page" provides a listing of drug names and safety
> labeling sections revised:
> http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm326133.htm > The following drugs had modifications to the CONTRAINDICATIONS and/or
> WARNINGS sections:
> Thanks again for your regular updates with these lists. There is one there I > take, (januvia) I think the benefits seem to outweigh the side effects for > now.
> Craig
>> From: FDA MedWatch
>> Date: 11/15/2012
>> Subject: FDA MedWatch - October 2012 Safety Labeling Changes includes
>> 58 products with revisions to Prescribing Information
>> The MedWatch October 2012 Safety Labeling Changes posting includes 58
>> products with safety labeling changes to the following sections:
>> CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS and
>> PATIENT PACKAGE INSERT.
>> The "Summary Page" provides a listing of drug names and safety
>> labeling sections revised:
>> http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm326133.htm >> The following drugs had modifications to the CONTRAINDICATIONS and/or
>> WARNINGS sections:
>> Thanks again for your regular updates with these lists. There is one >> there I take, (januvia) I think the benefits seem to outweigh the side >> effects for now.
>> Craig
> I dont see Januvia in that list.
> M.
Hi Maya,
It's in some of the combo drugs there ( Juvisync) and if you click on the link its listed there on its own also.
>>> From: FDA MedWatch
>>> Date: 11/15/2012
>>> Subject: FDA MedWatch - October 2012 Safety Labeling Changes includes
>>> 58 products with revisions to Prescribing Information
>>> The MedWatch October 2012 Safety Labeling Changes posting includes 58
>>> products with safety labeling changes to the following sections:
>>> CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS and
>>> PATIENT PACKAGE INSERT.
>>> The "Summary Page" provides a listing of drug names and safety
>>> labeling sections revised:
>>> http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm326133.htm >>> The following drugs had modifications to the CONTRAINDICATIONS and/or
>>> WARNINGS sections:
>>> Thanks again for your regular updates with these lists. There is one >>> there I take, (januvia) I think the benefits seem to outweigh the side >>> effects for now.
>>> Craig
>> I dont see Januvia in that list.
>> M.
> Hi Maya,
> It's in some of the combo drugs there ( Juvisync) and if you click on the > link its listed there on its own also.
> From: FDA MedWatch
> Date: 11/15/2012
> Subject: FDA MedWatch - October 2012 Safety Labeling Changes includes
> 58 products with revisions to Prescribing Information
> The MedWatch October 2012 Safety Labeling Changes posting includes 58
> products with safety labeling changes to the following sections:
> CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS and
> PATIENT PACKAGE INSERT.
> The "Summary Page" provides a listing of drug names and safety
> labeling sections revised:http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm326133.htm > The following drugs had modifications to the CONTRAINDICATIONS and/or
> WARNINGS sections:
> Thanks again for your regular updates with these lists. There is one there
> I take, (januvia) I think the benefits seem to outweigh the side effects for
> now.
> Craig
Yep. Sometimes it's a tough decision. Taking some medications can
do permanent harm, but confer benefit.
> >>> From: FDA MedWatch
> >>> Date: 11/15/2012
> >>> Subject: FDA MedWatch - October 2012 Safety Labeling Changes includes
> >>> 58 products with revisions to Prescribing Information
> >>> The MedWatch October 2012 Safety Labeling Changes posting includes 58
> >>> products with safety labeling changes to the following sections:
> >>> CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS and
> >>> PATIENT PACKAGE INSERT.
> >>> The "Summary Page" provides a listing of drug names and safety
> >>> labeling sections revised:
> >>>http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm326133.htm > >>> The following drugs had modifications to the CONTRAINDICATIONS and/or
> >>> WARNINGS sections:
> >>> Thanks again for your regular updates with these lists. There is one
> >>> there I take, (januvia) I think the benefits seem to outweigh the side
> >>> effects for now.
> >>> Craig
> >> I dont see Januvia in that list.
> >> M.
> > Hi Maya,
> > It's in some of the combo drugs there ( Juvisync) and if you click on the
> > link its listed there on its own also.
> > Best Wishes,
> > Craig
> Okay, thanks Craig :-)
> M.
Yes, that's a good point. Sometimes the FDA list is more complete
than the email version I get. Going to the link on the post should
get you to the complete list.
> From: FDA MedWatch
> Date: 11/15/2012
> Subject: FDA MedWatch - October 2012 Safety Labeling Changes includes
> 58 products with revisions to Prescribing Information
> The MedWatch October 2012 Safety Labeling Changes posting includes 58
> products with safety labeling changes to the following sections:
> CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS and
> PATIENT PACKAGE INSERT.
> The "Summary Page" provides a listing of drug names and safety
> labeling sections > revised:http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm326133.htm > The following drugs had modifications to the CONTRAINDICATIONS and/or
> WARNINGS sections:
> Thanks again for your regular updates with these lists. There is one there
> I take, (januvia) I think the benefits seem to outweigh the side effects > for
> now.
> Craig
Yep. Sometimes it's a tough decision. Taking some medications can
do permanent harm, but confer benefit.
Good Luck,
Chris
I tried stopping januvia for a while ( about a week) and felt like crap. Your own example of having to find your own way through the maze, to get to what works for you is illustrative of the tough decisions we must make in our quest for continuing health.
>>> From: FDA MedWatch
>>> Date: 11/15/2012
>>> Subject: FDA MedWatch - October 2012 Safety Labeling Changes includes
>>> 58 products with revisions to Prescribing Information
>>> The MedWatch October 2012 Safety Labeling Changes posting includes 58
>>> products with safety labeling changes to the following sections:
>>> CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS and
>>> PATIENT PACKAGE INSERT.
>>> The "Summary Page" provides a listing of drug names and safety
>>> labeling sections revised:
>>> http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm326133.htm >>> The following drugs had modifications to the CONTRAINDICATIONS and/or
>>> WARNINGS sections:
>>> Thanks again for your regular updates with these lists. There is one
>>> there I take, (januvia) I think the benefits seem to outweigh the side
>>> effects for now.
>>> Craig
>> I dont see Januvia in that list.
>> M.
> Hi Maya,
> It's in some of the combo drugs there ( Juvisync) and if you click on the
> link its listed there on its own also.
yeah. Chris always leaves out a couple just to check how sharp y'all are
>>>>> From: FDA MedWatch
>>>>> Date: 11/15/2012
>>>>> Subject: FDA MedWatch - October 2012 Safety Labeling Changes includes
>>>>> 58 products with revisions to Prescribing Information
>>>>> The MedWatch October 2012 Safety Labeling Changes posting includes 58
>>>>> products with safety labeling changes to the following sections:
>>>>> CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS and
>>>>> PATIENT PACKAGE INSERT.
>>>>> The "Summary Page" provides a listing of drug names and safety
>>>>> labeling sections revised:
>>>>> http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm326133.htm >>>>> The following drugs had modifications to the CONTRAINDICATIONS and/or
>>>>> WARNINGS sections:
>>>>> Thanks again for your regular updates with these lists. There is one
>>>>> there I take, (januvia) I think the benefits seem to outweigh the side
>>>>> effects for now.
>>>>> Craig
>>>> I dont see Januvia in that list.
>>>> M.
>>> Hi Maya,
>>> It's in some of the combo drugs there ( Juvisync) and if you click on the
>>> link its listed there on its own also.
>>> Best Wishes,
>>> Craig
>> Okay, thanks Craig :-)
>> M.
> Yes, that's a good point. Sometimes the FDA list is more complete
> than the email version I get.
Always putting the blame somewhere else...
But you can't fool
Don Roberto
>> From: FDA MedWatch
>> Date: 11/15/2012
>> Subject: FDA MedWatch - October 2012 Safety Labeling Changes includes
>> 58 products with revisions to Prescribing Information
>> The MedWatch October 2012 Safety Labeling Changes posting includes 58
>> products with safety labeling changes to the following sections:
>> CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS and
>> PATIENT PACKAGE INSERT.
>> The "Summary Page" provides a listing of drug names and safety
>> labeling sections revised:
>> http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm326133.htm >> The following drugs had modifications to the CONTRAINDICATIONS and/or
>> WARNINGS sections:
>> Thanks again for your regular updates with these lists. There is one >> there I take, (januvia) I think the benefits seem to outweigh the side >> effects for now.
>> Craig
